Ekaterina Noyes
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Community and Preventive Medicine |
|---|
| Address | Community & Preventive Medicine
265 Crittenden Blvd.
Rochester NY 14642
|
|---|
|
|
|
| 1994 |
-
| 1995 | Russian Presidential Scholarship for Research Abroad | | 1997 |
|
| Graduate Student Society Travel Award for First-Time Presentation | University of Rochester School of Medicine and Dentistry | | 2004 |
|
| Best Podium Presentation | International Society for Pharmacoeconomics & Outcomes Research | | 2004 |
|
| Excellence in Research Incentive Award | University of Rochester Medical School | | 2005 |
|
| Best Short Course Presentation | Society for Medical Decision Making 27th Annual Meeting | | 2007 |
|
| Dean's Teaching Fellowship | University of Rochester School of Medicine and Dentistry | | 2011 |
|
| Best Poster Award | International Society for Pharmacoeconomics and Outcomes Researc |
Dr. Noyes is Professor of Surgery and Public Health Sciences and Scientific Director of Surgical Health Outcomes and Research Enterprise (SHORE). She is a health services researcher with expertise in quality of care assessment, comparative effectiveness, and health outcomes and economic evaluations in healthcare. She is co-Director of Comparative Effectiveness Research (CER) Key Function Committee for the University of Rochester Clinical and Translation Science Institute, and co-Director of Center for Research Implementation and Translation (CRIT) at the URMC. Dr. Noyes has extensive experience working with interdisciplinary research teams on projects involving program evaluation, healthcare delivery and public health organizations funded by the NIH, AHRQ and other public and private sources. She has over 50 publications on quality measures, reimbursement, and cost-effectiveness of medical care. Dr. Noyes is has been involved in and led studies on evaluation of quality of life, cost and quality of long-term interventions, including cost-effectiveness of treatment for bladder, breast, and colorectal cancer, Parkinson's disease, and multiple sclerosis, use of implantable cardiac defibrillators, telemedicine, and effect of frailty on costs and quality of care.
-
Shprecher D, Noyes K, Biglan K, Wang D, Dorsey ER, Kurlan R, Adams MJ. Willingness of Parkinson's disease patients to participate in research using internet-based technology. Telemed J E Health. 2012 Nov; 18(9):684-7.
-
Noyes K, Veazie P, Hall WJ, Zhao H, Buttaccio A, Thevenet-Morrison K, Moss AJ. Cost-Effectiveness of Cardiac Resynchronization Therapy in the MADIT-CRT Trial. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):66-74.
-
Fan L, Mohile S, Zhang N, Fiscella K, Noyes K. Self-reported cancer screening among elderly medicare beneficiaries: a rural-urban comparison. J Rural Health. 2012 Jun; 28(3):312-9.
-
Heatwole C, Johnson N, Holloway R, Noyes K. Plasma Exchange versus Intravenous Immunoglobulin for Myasthenia Gravis Crisis: An Acute Hospital Cost Comparison Study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
-
Noyes K, Liu H, Lyness JM, Friedman B. Medicare beneficiaries with depression: comparing diagnoses in claims data with the results of screening. Psychiatr Serv. 2011 Oct; 62(10):1159-66.
-
Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW. Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology. 2011 Jul 26; 77(4):355-63.
-
Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med. 2011 Feb 1; 154(3):152-9.
-
Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011 Jan 26; 305(4):373-80.
-
Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: An overview. Urol Oncol. 2012 Mar; 30(2):126-32.
-
Ruan S, Noyes K, Bazarian JJ. The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. J Neurotrauma. 2009 Oct; 26(10):1655-64.
-
Madeb R, Golijanin D, Noyes K, Fisher S, Stephenson JJ, Long SR, Knopf J, Lyman GH, Messing EM. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors. Cancer. 2009 Jun 15; 115(12):2660-70.
-
McConnochie KM, Wood NE, Herendeen NE, Ng PK, Noyes K, Wang H, Roghmann KJ. Acute illness care patterns change with use of telemedicine. Pediatrics. 2009 Jun; 123(6):e989-95.
-
Liu H, Phelps CE, Veazie PJ, Dick AW, Klein JD, Shone LP, Noyes K, Szilagyi PG. Managed care quality of care and plan choice in New York SCHIP. Health Serv Res. 2009 Jun; 44(3):843-61.
-
Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs. 2009; 9(6):393-400.
-
Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009 Jan 1; 115(1):68-74.
-
Noyes K, Liu H, Temkin-Greener H. Medicare capitation model, functional status, and multiple comorbidities: model accuracy. Am J Manag Care. 2008 Oct; 14(10):679-90.
-
Noyes K, Singer EA, Messing EM. Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol. 2008 Sep; 18(5):533-9.
-
Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. Quantitative risk-benefit analysis of natalizumab. Neurology. 2008 Jul 29; 71(5):357-64.
-
Holland ML, Huston A, Noyes K. Cost-effectiveness of testing for breast cancer susceptibility genes. Value Health. 2009 Mar-Apr; 12(2):207-16.
-
O'Connor AB, Noyes K, Holloway RG. A cost-utility comparison of four first-line medications in painful diabetic neuropathy. Pharmacoeconomics. 2008; 26(12):1045-64.
-
Bonafede M, Dick A, Noyes K, Klein JD, Brown T. The effect of acupuncture utilization on healthcare utilization. Med Care. 2008 Jan; 46(1):41-8.
-
O'Connor AB, Noyes K, Holloway RG. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc. 2007 Aug; 55(8):1176-84.
-
Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007 Aug; 18(8):833-8.
-
Noyes K, Dick AW, Holloway RG. The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation. Med Decis Making. 2007 May-Jun; 27(3):327-34.
-
Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007 May; 45(5):377-85.
-
Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR. Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology. 2007 May 1; 68(18):1524-8.
-
Noyes K, Liu H, Holloway R, Dick AW. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14.
-
Piotrowicz K, Noyes K, Lyness JM, McNitt S, Andrews ML, Dick A, Hall WJ, Moss AJ, Zareba W. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J. 2007 Mar; 28(5):601-7.
-
Noyes K, Liu H, Temkin-Greener H. Cost of caring for Medicare beneficiaries with Parkinson's disease: impact of the CMS-HCC risk-adjustment model. Dis Manag. 2006 Dec; 9(6):339-48.
-
Noyes K, Liu H, Holloway RG. What is the risk of developing parkinsonism following neuroleptic use? Neurology. 2006 Mar 28; 66(6):941-3.
-
Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72.
-
Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38.
-
Noyes K, Dick AW, Holloway RG. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. Pharmacoeconomics. 2005; 23(12):1257-70.
-
Noyes K, Dick AW, Holloway RG. Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85.
-
Holloway R, Nesbit K, Bordley D, Noyes K. Teaching and evaluating first and second year medical students' practice of evidence-based medicine. Med Educ. 2004 Aug; 38(8):868-78.
-
Noyes K, Holloway RG. Evidence from cost-effectiveness research. NeuroRx. 2004 Jul; 1(3):348-55.
-
Custer AW, Kazarinova-Noyes K, Sakurai T, Xu X, Simon W, Grumet M, Shrager P. The role of the ankyrin-binding protein NrCAM in node of Ranvier formation. J Neurosci. 2003 Nov 5; 23(31):10032-9.
-
Chen C, Bharucha V, Chen Y, Westenbroek RE, Brown A, Malhotra JD, Jones D, Avery C, Gillespie PJ, Kazen-Gillespie KA, Kazarinova-Noyes K, Shrager P, Saunders TL, Macdonald RL, Ransom BR, Scheuer T, Catterall WA, Isom LL. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):17072-7.
-
Kazarinova-Noyes K, Shrager P. Molecular constituents of the node of Ranvier. Mol Neurobiol. 2002 Oct-Dec; 26(2-3):167-82.
-
Kazarinova-Noyes K, Malhotra JD, McEwen DP, Mattei LN, Berglund EO, Ranscht B, Levinson SR, Schachner M, Shrager P, Isom LL, Xiao ZC. Contactin associates with Na+ channels and increases their functional expression. J Neurosci. 2001 Oct 1; 21(19):7517-25.
-
Shrager P, Custer AW, Kazarinova K, Rasband MN, Mattson D. Nerve conduction block by nitric oxide that is mediated by the axonal environment. J Neurophysiol. 1998 Feb; 79(2):529-36.
|
Noyes's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
